Cholinergic-nitrergic transmitter mechanisms in the cerebral circulation

Microscopy Research and Technique

Volumn 53, Issue 2, 2001, Pages 119-128

  Lee, Tony J F ^a   Liu, Jie ^a   Evans, M Steven ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cerebral neurogenic vasodilation; Cholinergic and nitrergic innervation; L citrulline L arginine recycle; N type calcium channel; Presynaptic muscarinic M2 receptor

Indexed keywords

AMINO ACIDS; BLOOD VESSELS; BRAIN; CALCIUM; TRANSMITTERS;

CALCIUM CHANNELS; CEREBRAL NEUROGENIC VASODILATION; CHOLINERGIC AND NITRERGIC INNERVATION; CITRULLINE; L-ARGININE; L-CITRULLINE-L-ARGININE RECYCLE; N-TYPE CALCIUM CHANNEL; NITRIC OXIDE RELEASE; PRESYNAPTIC; PRESYNAPTIC MUSCARINIC M2 RECEPTOR;

NITRIC OXIDE;

ACETYLCHOLINE; CITRULLINE; CYCLIC GMP; MUSCARINIC RECEPTOR; NITRIC OXIDE;

ANIMAL TISSUE; ARTICLE; BRAIN ARTERY; BRAIN CIRCULATION; CAT; CHOLINERGIC SYSTEM; CONTROLLED STUDY; NEUROTRANSMITTER RELEASE; NONHUMAN; PRESYNAPTIC NERVE; PRIORITY JOURNAL; VASODILATATION;

EID: 0035870877     PISSN: 1059910X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jemt.1076     Document Type: Article

References (65)

1. 2+ current in rat magnocellular cholinergic basal forebrain neurons. J Physiol (Lond) 466:173-189.
2. Ayajiki K, Okamoto T, Toda N. 1993. Nitric oxide mediates, and acetylcholine modulates, neurally induced relaxation of bovine cerebral arteries. Neuroscience 54:819-825.
3. Boeckxstaens GE, De Man JG, De Winter BY, Moreels TG, Herman AG, Pelckmans PA. 1995. Bioassay and pharmacological characterization of the nitrergic neurotransmitter. Arch Int Pharmacodyn Ther 329:11-26.
4. Bredt DS, Snyder SH. 1990. Isolation of nitric oxide synthetase, a calmodulin requiring enzyme. Proc Natl Acad Sci USA 87:682-685.
5. Busija DW, Heistad DD. 1984. Factors involved in the physiological regulation of cerebral circulation. Rev Physiol Biochem Pharmacol 101:161-211.
6. Caulfield MP. 1991. Muscarinic receptor-mediated inhibition of voltage-activated Ca current in neuroblastoma x glioma hybrid (NG-108) cells: reduction of muscarinic agonist and antagonist potency by tetraethylammonium (TEA). Neurosci Lett 127:165-168.
7. Caulfield MP. 1993. Muscarinic receptors-characterization, coupling and function. Pharmacol Ther 58:319-379.
8. Chen F, Lee TJF. 1993. Role of nitric oxide in neurogenic vasodilation of porcine cerebral artery. J Pharmacol Exp Ther 265:339-345.
9. Chen F, Lee TJF. 1995. Arginine synthesis from citrulline in perivascular nerves of cerebral artery. J Pharmacol Exp Ther 273:895-901.
10. Chorobski J, Penfield W. 1932. Cerebral vasodilator nerves and their pathway from the medulla oblongata. Arch Neurol Psychiatry 28: 1257-1289.
11. Duckies SP. 1981. Evidence for a functional cholinergic innervation of cerebral arteries. J Pharmacol Exp Ther 217:544-548.
12. Edvinsson L, Mackenzie ET, McCulloch J. 1993. Cerebral blood flow and metabolism. Raven Press, New York.
13. Florence VM, Bevan JA. 1979. Biochemical determination of cholinergic innervation in cerebral arteries. Circ Res 45:212-218.
14. Gahwiler BH, Brown DA. 1987. Muscarine affects calcium-currents in rat hippocampal pyramidal cell in vitro. Neurosci Lett 76:301-306.
15. G-monomethyl arginine in endothelium denuded vessels. Br J Pharmacol 102:567-572.
16. Gonzalez C, Estrada C. 1991. Nitric oxide mediates the neurogenic vasodilatation of bovine cerebral arteries. J Cereb Blood Flow Metab 11:366-370.
17. Gonzalez C, Barroso C, Martin C, Gulbenkian S, Estrada C. 1997. Neuronal nitric oxide synthase activation by vasoactive intestinal peptide in bovine cerebral arteries. J Cereb Blood Flow Metabolism 17:977-984.
18. Gotoh J, Fukuuchi Y, Koto A, Suzuki N, Naganuma Y, Isozumi K, Matsuoka S, Shimizu T. 1993. Mechanism of cerebrovascular neurogenic vasodilation: Effect of atropine on vasodilation of pial vessels upon parasympathetic nerve stimulation. J Cereb Blood Flow Metab 13(Suppl 1)S185.
19. Hulme EC, Birdsall NJM, Buckley NJ. 1990. Muscarinic receptor subtypes. Ann Rev Pharmacol Toxicol 30:633-673.
20. Jackson MJ, Beaudet AL, and O'Brien WE. 1986. Mammalian urea cycle enzymes. Rev Genet 20:431-464.
21. Kimura T, Yu JG, Edvinsson L, Lee TJF. 1997. Cholinergic, nitric oxidergic innervation in cerebral arteries of the cat. Brain Res 773:117-124.
22. Lee TJF. 1980. Direct evidence against acetylcholine as the dilator transmitter in the cat cerebral arteries. Eur J Pharmacol 68:393-394.
23. Lee TJF. 1982. Cholinergic mechanisms in the large cat cerebral arteries. Circ Res 50:870-879.
24. Lee TJF. 1986. Sympathetic and nonsympathetic transmitter mechanisms in cerebral vasodilation and constriction. In: Owman C, Hardebo JE, editors. Neural regulation of brain circulation. New York: Elsevier, p 285-296.
25. Lee TJF. 1994. Putative transmitters in cerebral neurogenic vasodilation. In: Bevan JA, Bevan RD, Walters CL, editors. The human brain circulation: functional changes in disease. Totowa, New Jersey: Humana Press, pp 73-91.
26. Lee TJF, Sarwinski S. 1991. Nitric oxidergic neurogenic vasodilation in basilar arteries of the pig. Blood Vessels 28:407-412.
27. Lee TJF, Su C, Bevan JA. 1975. Nonsympathetic dilator innervation of cat cerebral arteries. Experientia 31:1424-1425.
28. Lee TJF, Kinkead L, Sarwinski S. 1982. Transmitter role of norepinephrine and acetylcholine in pig cerebral arteries. J Cereb Blood Flow Metab 2:439-450.
29. Lee TJF, McIlhany MP, Sarwinski S. 1984. Erythrocyte extracts enhance neurogenic vasoconstriction of cerebral arteries in vitro. J Cereb Blood Flow Metab 4:474-476.
30. Lee TJF, Linnik MD, Shirasaki H, Imai H, McIlhaney MP, Yu JG. 1988. Neurogenic vasodilation in large cerebral arteries of the cat. In Vanhoutte PM, editor. Vasodilation: vascular smooth muscle, peptides, autonomic nerves, and endothelium. New York; Raven Press, p 101-106.
31. Lee TJF, Linnik MD, Miao FJP. 1988. Erythrocyte extracts and cerebral vascular function. In: Bevan JA, Majewski H, Maxwell RA, Story DF, editors. IRL Press. pp 299-309.
32. Lee TJF, Fang YX, Nickols GA. 1989. Cyclic nucleotides and cerebral neurogenic vasodilation. In: Seylaz J, MacKenzie ET, editors. Neurotransmission and Cerebrovascular Function. Elsevier. pp 277-280.
33. Lee TJF, Chen FY, Sarwinski S. 1993. Role of NO, VIP and CGRP in cerebral neurogenic vasodilation. J Cereb Blood Flow Metab 13(Suppl 1):S264.
34. Lee TJF, Sarwinski S, Ishine T, Lai C, Chen FY. 1996. Inhibition of cerebral neurogenic vasodilation by L-glutatmine and nitric oxide synthase inhibitors. J Pharmacol Exp Ther 267:353-358.
35. Lee TJF, Zhang W, Sarwinski S. 2000. Presynaptic beta2-adrenoceptors mediate nicotine-induced NOergic neurogenic vasodilation in the pig cerebral arteries. Am J Physiol Heart Circ Physiol 279: H808-16.
36. Liu J, Lee TJF. 1999. Mechanism of prejunctional muscarinic receptor-mediated inhibition of neurogenic vasodilation in cerebral arteries. Am J Physiol 276:H194-H204.
37. 2+ channels in cerebral perivascular NOergic nerves. Society of Neuroscience 25:1504.
38. 2+-channels in cultured rat sphenopalatine ganglion neurons: an immunohistochemical and electrophysiological study. J Cereb Blood Flow Metab 20:183-191.
39. Loesch A, Belai A, Burnstock G. 1994. An ultrastructural study of NADPH diaphorase and nitric oxide synthase in the perivascular nerves and vascular endothelium of the rat basilar artery. J Neurocytol 23:49-59.
40. McCleskey EW, Fox AP, Feldman DH, Cruz LJ, Olivera BM, Tsien RW, Yoshikami D. 1987. ω-Conotoxin: direct and persistent blockade of specific types of calcium channels in neurons but not muscle. Proc Natl Acad Sci USA 84:4327-4331.
41. Miao FJP, Lee TJF. 1991. VIP-ergic and cholinergic innervation in internal carotid arteries of the cat and rat. J Cardiovascular Pharmacol 18:369-378.
42. 1 muscarinic receptors. J Pharmacol Exp Ther 253:310-314.
43. Miller RJ. 1987. Multiple calcium channels and neuronal function. Science. 235:46-52.
44. 2 muscarinic receptors causes an alteration of action potentials by modulation of Ca entry in isolated sympathetic neurons of rabbits. Neurosci Lett 72:199-204.
45. Morris SM Jr., Sweeney WE Jr., Kepka DM, O'Brien WE, Avner ED. 1991. Localization of arginine biosynthetic enzymes in renal proximal tubules and abundance of mRNA during development. Pediatr Res 29:151-154.
46. 2 receptor subtypes. Br J Pharmacol 96:319-324.
47. Nozaki K, Maskowitz MA, Maynard KI, Koketsu N, Dawson TM, Bredt DS, Snyder S H. 1993. Possible origins and distribution of immunoreactive nitric oxide synthase-containing nerve fibers in cerebral arteries. J Cereb Blood Flow Metab 13:70-79.
48. Ogilvie P, Schilling K, Billingsley RIL, Schmidt HHHW. 1995. Induction and variants of neuronal nitric oxide synthase type I during synaptogenesis. FASEB J 9:799-806.
49. Palmer RMJ, Moncada S. 1989. A novel citrulline-forming enzyme implicated in the formation of nitric oxide by vascular endothelial cells: Biochem Biophys Res Commun 158:348-352.
50. Ratner S. 1973. Enzymes of arginine and urea synthesis. Adv Enzym 39:1-90.
51. Saito A, Wu JU, Lee TJF. 1985. Evidence for the presence of cholinergic nerves in cerebral artery. An immunohistochemical demonstration of choline acetyltransferase. J Cereb Blood Flow Metab 5:327-334.
52. Sato A, Sato Y. 1995. Cholinergic neural regulation of regional cerebral blood flow. Alzheimer Dis Assoc Disord 9:28-38.
53. Suzuki N, Hardebo JE. 1993. The cerebrovascular parasyrnpathetic innervation. Cerebrovasc Brain Metab Rev 5::33-46.
54. Toda N. 1982. Relaxant responses to transneural nerve stimulation and nicotine of dog and monkey cerebral arteries. Am J Physiol 243-.H145-H153.
55. G-monomethyl arginine (L-NMMA) of the response to nerve stimulation in isolated dog mesenteric and cerebral arteries. Jpn J Pharmacol 52:170-173.
56. Toda N, Ayajiki K, Okamura T. 1997. Inhibition of nitroxidergic nerve function by neurogenic acetylcholine in monkey cerebral arteries. J Physiol (Lond) 498:453-461.
57. Tse A, Clark RB, Giles WR. 1990. Muscarinic modulation of calcium current in neurons from the interatrial septum of bull-frog heart. J Physiol (Lond) 427:127-149.
58. Uchida S, Kagitani F, Nakayama H, Sato A. 1997. Effect of stimulation of nicotinic cholinergic receptors on cortical cerebral blood flow and changes in the effect during aging in anesthetized rats. Neurosci Lett 228:203-206.
59. Vasquez J, Purves MJ. 1997. Studies on the dilator pathway to cere-bral blood vessels. In Owman CH, Edvinsson L, editors. Neurogenic control of the brain circulation. Oxford: Plenum Press, p 59-73.
60. 2+ current in rat sympathetic neurons. Proc Natl Acad Sci USA 84:4313-4317.
61. Yu JG, Wu JY, Lee TJF. 1992. Choline acetyltransferase immunoreactivities in cerebral blood vessels. Chin J Pharmacology and Toxicology 6:28-34.
62. Yu JG, Ishine T, Kimura T, O'Brien WE, Lee TJF. 1997a. L-citrulline conversion to L-arginine in sphenopalatine ganglia and cerebral perivascular nerves in the pig. Am J Physiol 273: H2192-H2199.
63. Yu JG, O'Brien WE, Lee TJF. 1997b. Morphological evidence for L-citrulline conversion to L-arginine via the argininosuccinate pathway in porcine cerebral perivascular nerves. J Cereb Blood Flow Metab 17:884-893.
64. Yu JG, Kimura T, Chang XF, Lee TJF. 1998. Segregation of VIPergic-nitric oxidergic and cholinergic-nitric oxidergic innervation in porcine middle cerebral arteries. Brain Res 801:78-87.
65. Zhang W, Edvinsson L, Lee TJF. 1998. Mechanism of nicotine-induced relaxation in the porcine basilar artery. J Pharmacol Exp Ther 284:790-797.